Updated guidelines include detailed recommendations and information in the context of greatly expanded OPAT use in recent years.
Sponsoring Organization: Infectious Diseases Society of America (IDSA)Target Audience: Infectious disease clinicians and others caring for patients receiving outpatient parenteral antimicrobial therapy (OPAT)
Background and Objective
In 2004, IDSA guidelines introduced OPAT and focused on safe delivery systems. The new guidelines build on the previous version and have expanded sections on treatment logistics, antimicrobial selection and monitoring, vascular access devices and complications, and common toxicities.
Key Points
OPAT administered at home by patients or their caregivers is a safe and effective option for completion of antimicrobial therapy.
Before OPAT initiation, an infectious diseases (ID) expert should review all cases. This review…
Reviewing Authors
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)